Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Oct 16, 2014; 2(10): 596-603
Published online Oct 16, 2014. doi: 10.12998/wjcc.v2.i10.596
Published online Oct 16, 2014. doi: 10.12998/wjcc.v2.i10.596
Ref. ranges | Pre-operative | Pre-CPB | Rewarming Haemostatic intervention: FFP 15 mg/kg | Immediately post separation from CPB Haemostatic intervention: Protamine 500 mg; DDAVP 0.3 mg/kg; Concentrated fibrinogen 4 g;Platelets 2 pooled doses; 2 units packed RBC | 15 min post separation from CPB Haemostatic intervention: Prothrombine × 1000 IU; then continuous infusion at 100 IU /h | 30-min post separation from CPB Haemostatic intervention: Nil | Arrival intensive care unit | |
R (min) | 4-8 | 6.4 | 5.0 | 6.7 | 6.9 | 28.9 | 7.8 | 6.7 |
K (min) | 0-4 | 2.0 | 1.8 | 1.8 | 1.8 | 4.9 | 1.5 | 1.6 |
Angle (deg) | 47-74 | 62.7 | 63.5 | 65.6 | 65.2 | 49.6 | 68.5 | 65.5 |
MA (mm) | 54-72 | 53.7 | 61.9 | 61.3 | 57.6 | 71.8 | 69.0 | 70.1 |
LY30 (%) | 0-8 | 0.7 | 0.3 | 0.0 | 0.0 | 1.4 | 0.0 | 0.0 |
INR | - | 1.3 | 1.2 | 1.4 | 1.7 | 1.5 | 1.4 | 1.4 |
PT | 11-15 s | 13 s | 14 s | 15 s | 19 h | 17 h | 16 h | 16 h |
APPT | 22-38 s | 36 s | 39 h | > 200 h | 49 h | 50 h | 45 h | 38 s |
Fib clauss | 2.0-4.0 g/L | 2.3 g/L | 1.3 L | 2.6 g/L | 2.0 g/L | 1.6 L | 1.8 g/L | |
D-dimer | < 0.23 mg/L | 1.05 h | Not measured | 0.94 h | 1.15 mg/L | Not measured | Not measured | |
Hb | 130-180/L | 90 L | 83 L | 73 L | 55 L | 85 L | Not measured | 71 L |
WBC | 4.0-11.0 × 109 | 3.9 L | 4.2 × 109 | 10.8 × 109 | 8.2 × 109 | 11.7 h | Not measured | 9.4 × 109 |
Platelets | 150-400 × 109 | 76 L | 64 L | 57 L | 140 L | 120 L | Not measured | 73 L |
Ref. ranges | Pre-operation | Pre-cardiopulmonary bypass | Rewarming | Post separation | Closure | Post-op day 1 | Post-op day 2 (venous) | |
pH | 7.35-7.45 | 7.341 | 7.321 | 7.371 | 7.241 | 7.341 | 7.341 | 7.331 |
pCO2 (mmHg) | 35-45 | 37 | 38 | 35 | 502 | 42 | 39 | 45 |
pO2 (mmHg) | 80-110 | 105 | 2302 | 3882 | 3852 | 4042 | 1112 | 331 |
HCO3- (mmol/L) | - | 19 | 19 | 20 | 20 | 22 | 20 | 23 |
Base excess (mmol/L) | -3/+3 | -61 | -61 | -41 | -61 | -3 | -51 | -2 |
O2 sat (%) | > 94 | 98 | 100 | 100 | 100 | 100 | 100 | 561 |
Na+ (mmol/L) | 135-148 | 1321 | 1322 | 136 | 138 | 138 | 138 | 1301 |
K+ (mmol/L) | 3.5-5.3 | 4.0 | 4.0 | 4.9 | 3.9 | 3.9 | 4.6 | 4.5 |
Cl- (mmol/L) | 95-106 | 1071 | 1072 | 106 | 1082 | 1082 | 106 | 99 |
Ionised Ca2+ (mmol/L) | 1.13-1.32 | 1.16 | 1.071 | 0.921 | 0.831 | 1.061 | 1.101 | 1.101 |
Haemoglobin (g/L) | 120-180 | 801 | 781 | 711 | 771 | 861 | 711 | 631 |
Glucose (mmol/L) | 0.0-5.0 | 5.92 | 6.32 | 8.32 | 6.22 | 3.81 | 8.02 | 8.92 |
Lactate (mmol/L) | 3.9-5.8 | 0.9 | 0.6 | 4.02 | 2.92 | 2.02 | 1.5 | 1.3 |
- Citation: Weinberg L, Kearsey I, Tjoakarfa C, Matalanis G, Galvin S, Carson S, Bellomo R, McNicol L, McCall P. Haemostatic management for aortic valve replacement in a patient with advanced liver disease. World J Clin Cases 2014; 2(10): 596-603
- URL: https://www.wjgnet.com/2307-8960/full/v2/i10/596.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i10.596